Implant Sciences receives follow-on order from Kuehne + Nagel to provide QS-B220

US-based Implant Sciences has received a follow-on order worth about $500,000 from logistics firm Kuehne + Nagel to supply QS-B220 explosives trace detectors.

Kuehne + Nager will deploy the QS-B220s across its ten facilities for air cargo screening in the US. The company first ordered the explosives trace detectors in 2014.

Implant Sciences global sales and marketing vice-president Dr Darryl Jones said: "We were very pleased to receive this follow on order, which is more than twice the size of the first purchase by one of the largest logistics companies in the world.

"Based on feedback we’ve received from Kuehne +Nagel the factors driving their decision included the favourable low cost of maintenance for our systems, as compared with the competing systems being replaced by our QS-B220s.

"Remote diagnostics and push-button maintenance also reduced both down-time and maintenance expenses for our customer."
The QS-B220 will use Ion Mobility Spectrometry (IMS) to quickly detect and identify trace amounts of different military, commercial, and homemade explosives, in addition to illicit drugs.

According to the company, it can be deployed for a lower total cost of ownership than other approved products, with significantly lower maintenance requirements.

The QS-B220 features radioactive material-free design and push-button maintenance and diagnostics and patented inCal internal automatic calibration system, allowing desktop trace detection users to perform better conveniently.

Implant Sciences produces explosives trace detection and drugs trace detection solutions for homeland security applications.